http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100875437-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A47B2220-0097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A47B2220-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B43L1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A47B97-001 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100875437-B1 |
| titleOfInvention | NPC1 gene involved in self-renewal and differentiation of neural stem cells and uses thereof |
| abstract | The present invention is based on identifying a new function that NPC1 gene is involved in the self-regeneration and differentiation of neural stem cells, NPC1 gene involved in the self-reproduction and differentiation of neural stem cells, the NPC1 Gene therapy agent for the treatment of diseases caused by stem cell regeneration or differentiation, such as degenerative nervous system disease, myocardial infarction, etc. comprising the gene carrier containing the gene as an active ingredient and the NPC1 The present invention relates to a cell therapy agent for treating diseases caused by poor stem cell regeneration or differentiation, such as neurodegenerative diseases, myocardial infarction, and the like, including neuronal stem cells containing genes as active ingredients.n n n n NPC1 gene, Neiman peek disease, cell therapy |
| priorityDate | 2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.